Status:

COMPLETED

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance

Lead Sponsor:

London School of Hygiene and Tropical Medicine

Collaborating Sponsors:

Instituto Nacional de Saúde, Mozambique

Georgia Institute of Technology

Conditions:

Rotavirus Infections

Environmental Enteric Dysfunction

Eligibility:

FEMALE

16+ years

Brief Summary

This is a controlled cohort study to assess the effect of improved sanitation on oral rotavirus vaccine performance in low-income urban neighbourhoods of Maputo, Mozambique. The specific hypotheses ar...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Mother residing in an intervention or control compound of a previous sanitation trial (NCT02362932) for at least 6 months prior to recruitment and not intending to switch study compound over the next 9 months
  • Mother being pregnant and having gestational age between 3 and 9 months or being puerperal (up to 40 days postpartum)
  • Mother planning to use the prenatal care, delivery and vaccination services provided by the Ministry of Health of Mozambique
  • Mother able to understand and complete the informed consent process and allow your newborn to participate in the study
  • Mother at least 16 years of age
  • Infant eligible to receive rotavirus vaccination
  • Exclusion criteria:
  • Infant whose medical team considers that they cannot be part of the study
  • Infant with complications associated with gestation, childbirth or postpartum, including congenital malformations
  • Infant with any medical, psychiatric or social condition, occupational reason, or other responsibility on the part of the pregnant woman, which, in the opinion of the investigator, is a contraindication to protocol compliance or impedes the participant's ability to give informed consent
  • Infant who has already received the rotavirus vaccine

Exclusion

    Key Trial Info

    Start Date :

    October 5 2017

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 12 2024

    Estimated Enrollment :

    261 Patients enrolled

    Trial Details

    Trial ID

    NCT03313128

    Start Date

    October 5 2017

    End Date

    December 12 2024

    Last Update

    December 26 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centro de Investigação em Saúde da Polana Caniço (CISPOC)

    Maputo, Mozambique, 264